Epinephrine Autoinjector Market to Grow by USD 2.44 Billion (2024-2028), Rising Allergy Prevalence Boosts Growth, with AI Powering Market Evolution
NEW YORK, Jan. 31, 2025 /PRNewswire/ -- Report on how AI is driving market transformation - The global epinephrine autoinjector market size is estimated to grow by USD 2.44 billion from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of over 10.59% during the forecast period. Increasing prevalence of allergies is driving market growth, with a trend towards frequent product launches due to government pressure on vendors. However, product recalls and regulatory issues poses a challenge. Key market players include Adamis Pharmaceuticals Corp., ALK Abello AS, Amneal Pharmaceuticals Inc., Bausch Health Companies Inc., BIOPROJET, Crossject, Halozyme Therapeutics Inc., kaleo Inc., Pfizer Inc., Teva Pharmaceutical Industries Ltd., and Viatris Inc..
Key insights into market evolution with AI-powered analysis. Explore trends, segmentation, and growth drivers- View Free Sample PDF
Epinephrine Autoinjector Market Scope
Report Coverage
Details
Base year
2023
Historic period
2018 - 2022
Forecast period
2024-2028
Growth momentum & CAGR
Accelerate at a CAGR of 10.59%
Market growth 2024-2028
USD 2.44 billion
Market structure
Concentrated
YoY growth 2022-2023 (%)
8.78
Regional analysis
North America, Europe, Asia, and Rest of World (ROW)
Performing market contribution
North America at 46%
Key countries
US, Germany, UK, China, and Japan
Key companies profiled
Adamis Pharmaceuticals Corp., ALK Abello AS, Amneal Pharmaceuticals Inc., Bausch Health Companies Inc., BIOPROJET, Crossject, Halozyme Therapeutics Inc., kaleo Inc., Pfizer Inc., Teva Pharmaceutical Industries Ltd., and Viatris Inc.
Market Driver
The Epinephrine Autoinjector market is witnessing significant trends due to the rising acceptance and increased awareness of these life-saving devices. These handheld devices, also known as epinephrine pens or Epis, are used for self administration during acute anaphylactic reactions caused by allergic diseases such as insect bites or stings. Epinephrine, also known as adrenaline, is a vital medication that counteracts the effects of severe allergic responses by constricting blood vessels and increasing blood flow. Healthcare professionals recommend epinephrine autoinjectors for prompt intervention during anaphylactic shock. The market is seeing in demand for pre-filled, specific dose autoinjectors, including needle-free injectors and innovative technologies. Consumer preference for convenient and user-friendly devices is driving the market. Companies like Amphastar Pharmaceuticals are introducing generic versions to cater to the increasing demand and decreasing the burden of allergies. However, recurring product recalls and the rate of diagnosis remain challenges. Digital health platforms and autoinjector training are essential to improve patient awareness and ensure proper usage.
The US epinephrine autoinjector market is expected to experience several new product launches in the upcoming years due to increased pressure from the US government for FDA approval of generic alternatives to leading brands like Viatriss EpiPen. This follows the price increase of Viatriss EpiPen, prompting US Governor Margaret Wood Hassan to advocate for more options. Companies such as Bausch Health and ALK Abello, with significant European market presence, may enter the US market in response to this initiative. For instance, Teva Pharmaceutical Industries launched their AJOVY in the prefilled YpsoMate 2 in March 2020.
Request Sample of our comprehensive report now to stay ahead in the AI-driven market evolution!
Market Challenges
The Epinephrine Autoinjector market faces challenges in ensuring accurate dosage for various age groups during acute anaphylactic reactions caused by allergic diseases, such as insect bites or stings. Healthcare professionals emphasize the importance of prompt intervention with epinephrine, also known as Adrenaline, as a life-saving medication for severe allergic reactions. Epinephrine autoinjectors, like epipens and epinephrine pens, are handheld devices that provide convenience and consumer preference for self-administration. However, challenges persist in the form of recurring product recalls, rising acceptance of generic goods from companies like Amphastar Pharmaceuticals, and increasing awareness of innovative technologies like needle-free injectors. Digital health platforms and autoinjector training aim to improve patient awareness and counteract the burden of allergies, while pre-filled, specific dose epinephrine autoinjectors continue to be essential for bronchodilator effects that improve blood flow and counteract anaphylactic shock.
The epinephrine autoinjector market has encountered challenges due to product recalls and regulatory hurdles. FDA approval for these devices has been a lengthy process, enabling Viatris to dominate the US market. Following Sanofi's exit, Viatris held a monopoly, partly due to the FDA's limited approval of competitors' products and partly because Impax Laboratories (now Amneal Pharmaceuticals) lacked an automated manufacturing facility for generic Adrenaclick supply. Given the critical importance of accurate epinephrine dose delivery during anaphylactic shock emergencies, product recalls are a necessary response.
Discover how AI is revolutionizing market trends- Get your access now!
Segment Overview
This epinephrine autoinjector market report extensively covers market segmentation by
Type
1.1 0.30gm
1.2 0.15gm
1.3 0.50gm
End-user
2.1 Hospitals
2.2 clinics
2.3 Homecare
Geography
3.1 North America
3.2 Europe
3.3 Asia
3.4 Rest of World (ROW)
Age Group
1.1 0.30gm- The global epinephrine autoinjector market for the 0.30gm dosage segment is projected to experience significant growth due to increasing sales of generic options. Amneal Pharmaceuticals' Adrenaclick and Viatris' upcoming generic EpiPen have gained traction following price hikes by key players. In Europe, market share for Viatris may decline due to the availability of multiple brands. The gradual price increases by Viatris and the exit of competitors have encouraged research and development of alternatives, ensuring market expansion for epinephrine autoinjectors in the forecast period.
Download a Sample of our comprehensive report today to discover how AI-driven innovations are reshaping competitive dynamics
Research Analysis
Epinephrine autoinjectors are handheld devices used to deliver a pre-measured dose of epinephrine during acute anaphylactic reactions. These injectors are essential for individuals with allergic diseases, particularly those prone to severe allergic responses from insect bites or stings. The dosage in epinephrine autoinjectors varies, but they are typically designed for use by individuals or their caregivers, making them accessible during emergencies. Epinephrine, also known as adrenaline, is a vital medication for reversing anaphylaxis, a life-threatening allergic response. Innovative technologies have led to the development of needle-free injectors and generic epinephrine autoinjectors, increasing acceptance and accessibility in the healthcare industry. Epinephrine autoinjectors come in different brands like epinephrine pens and EpiPens, catering to various age groups.
Market Research Overview
Epinephrine autoinjectors, also known as epinephrine pens or EpiPens, are handheld devices that deliver a specific dose of epinephrine, a life-saving medication for individuals experiencing acute anaphylactic reactions due to allergic diseases such as insect stings or food allergies. These devices are essential for prompt intervention during severe allergic responses, counteracting the effects of narrowing blood vessels and decreased blood flow caused by anaphylaxis. The market for epinephrine autoinjectors is witnessing increasing acceptance and awareness, driven by the convenience and consumer preference for self-administration devices. The rising burden of allergies and the need for prompt intervention have led to the development of innovative technologies, including needle-free injectors and digital health platforms for autoinjector training. The market includes pre-filled epinephrine autoinjectors in various dosages for different age groups, with both branded and generic versions available. However, recurring product recalls and the rate of diagnosis remain challenges for the industry. Epinephrine, also known as adrenaline, is a vital medication used to treat anaphylactic shock, a potentially fatal allergic reaction.
Table of Contents:
1 Executive Summary2 Market Landscape3 Market Sizing4 Historic Market Size5 Five Forces Analysis6 Market Segmentation
Type
End-user
Geography
Age Group
7 Customer Landscape8 Geographic Landscape9 Drivers, Challenges, and Trends10 Company Landscape11 Company Analysis12 Appendix
About Technavio
Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.
With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
Contacts
Technavio ResearchJesse MaidaMedia & Marketing ExecutiveUS: +1 844 364 1100UK: +44 203 893 3200Email: media@technavio.comWebsite: www.technavio.com/
View original content to download multimedia:https://www.prnewswire.com/news-releases/epinephrine-autoinjector-market-to-grow-by-usd-2-44-billion-2024-2028-rising-allergy-prevalence-boosts-growth-with-ai-powering-market-evolution---technavio-302365325.html
SOURCE Technavio
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
24 minutes ago
- Yahoo
Thunderbird Entertainment Retains Three Part Advisors for Its Investor Relations Program
VANCOUVER, British Columbia, June 11, 2025--(BUSINESS WIRE)--Thunderbird Entertainment Group Inc. (TSXV: TBRD, OTCQX: THBRF) ("Thunderbird" or the "Company") is pleased to announce that it has retained Three Part Advisors, LLC ("Three Part Advisors"), a leading full-service, strategic investor relations advisory firm headquartered near Dallas, Texas, for its ongoing investor relationship program, effective July 1, 2025. Three Part Advisors will work closely with management on the Company's strategic investor relations program, with a focus on enhancing Thunderbird's visibility within the investment community. This includes, but is not limited to, identifying and engaging with potential investors, organizing investor presentations and meetings with interested parties, responding to incoming calls from shareholders and potential investors, and providing general capital markets advisory services. Jennifer Twiner McCarron, CEO and Chair of Thunderbird, commented, "We're pleased to welcome Three Part Advisors as our new strategic investor relations advisory firm. Given our significant growth plans and the health of our business, we believe this is an opportune time to share the Thunderbird story with a broader investor audience." Steven Hooser, Partner of Three Part Advisors, said, "We are thrilled to welcome Thunderbird Entertainment to our growing base of diverse clients. We know that introducing the Company to the right investors looking for growth and a strong management team is vital, and Thunderbird has built a global content creation studio of premium, award-winning content and distribution that will generate excitement from fundamental investors across our network." Three Part Advisors has been retained for an initial period of one year, commencing July 1, 2025, at a rate of $12,500 USD per month. Three Part Advisors has no interest, directly or indirectly, in the Company or its securities, or any right or intent to acquire such an interest, other than as described herein. Market Making Services Correction Thunderbird is correcting language from an announcement made on October 23, 2024. The agreement with the Independent Trading Group to provide market making services in accordance with TSX Venture Exchange policies was for an initial term of one month and renewable thereafter. About Three Part Advisors, LLC Three Part Advisors, LLC is a leading full-service, strategic investor relations advisory firm. Through measurable and proactive investor relations programs, the firm helps clients develop their investment thesis, effectively communicate the strategy to Wall Street, meet new investors and ultimately, lower the cost of capital. Three Part Advisors also provides corporate design services and annually holds three independent IDEAS investor conferences ( Unbiased by investment banking fees and trading commissions, Three Part Advisors has a proven reputation for engaging with companies that are supported by strong investment merits and proven fundamentals, and proactively communicating their stories to Wall Street in the most effective manner. More information is available at About Thunderbird Entertainment Thunderbird Entertainment (TSXV: TBRD, OTCQX: THBRF) is a global award-winning, full-service multiplatform production, distribution and rights management company, headquartered in Vancouver, with teams in Los Angeles and Ottawa. Thunderbird creates award-winning scripted, unscripted, and animated programming for the world's leading digital platforms, as well as Canadian and international broadcasters. The Company develops, produces, and distributes animated, factual, and scripted content through its various content arms, including Thunderbird Kids and Family (Atomic Cartoons), Thunderbird Unscripted (Great Pacific Media) and Thunderbird Scripted. Productions under the Thunderbird umbrella include Mermicorno: Starfall, Super Team Canada, Molly of Denali, Highway Thru Hell, Kim's Convenience, Boot Camp and Sidelined: The QB and Me. Thunderbird Distribution and Thunderbird Brands manage global media and consumer products rights, respectively, for the Company and select third parties. Thunderbird is on Facebook, X, and Instagram at @tbirdent. For more information, visit: Neither the TSXV nor its Regulation Services Provider (as that term is defined in the policies of the TSXV) accepts responsibility for the adequacy or accuracy of this release, which has been prepared by management. Cautionary Statement Regarding Forward-Looking Information Certain statements contained in this news release may contain forward-looking information or may be forward-looking statements (collectively, "forward-looking statements") within the meaning of applicable securities laws. Forward-looking statements may be identified by words such as "anticipate", "continue", "estimate", "expect", "forecast", "may", "will", "plan", "project", "should", "believe", "intend", or similar expressions concerning matters that are not historical facts. Forward-looking statements in this press release include, but are not limited to, statements regarding Thunderbird's retention of Three Part Advisors, LLC as its new investor relations advisory firm, the anticipated benefits of this engagement, including enhancing Thunderbird's visibility within the investment community, increasing investor awareness and engagement, supporting the Company's growth and shareholder value, and the implementation of a proactive investor awareness program aimed at increasing shareholder engagement, trading volume, and attracting long-term investors. Forward-looking statements are necessarily based on a number of estimates and assumptions that, while considered reasonable, are subject to known and unknown risks, uncertainties and other factors which may cause actual results and future events to differ materially from those expressed or implied by such forward-looking statements. Such factors include, but are not limited to: general business, economic and social uncertainties; litigation, legislative, environmental and other judicial, regulatory, political and competitive developments; product capability and acceptance; international risk and currency exchange rates; and technology changes. The forward-looking statements or information contained in this document represent our views as of the date hereof and as such information should not be relied upon as representing our views as of any date subsequent to the date of this document. The Company undertakes no obligation to update publicly or revise any forward-looking statements or information, whether as a result of new information, future events or otherwise, unless so required by applicable securities laws. Accordingly, readers are cautioned not to place undue reliance on forward-looking statements or information. View source version on Contacts Media Relations & Corporate Communications: Julia Smith, Finch MediaEmail: Julia@
Business Wire
28 minutes ago
- Business Wire
Thunderbird Entertainment Retains Three Part Advisors for Its Investor Relations Program
VANCOUVER, British Columbia--(BUSINESS WIRE)--Thunderbird Entertainment Group Inc. (TSXV: TBRD, OTCQX: THBRF) (' Thunderbird ' or the ' Company ') is pleased to announce that it has retained Three Part Advisors, LLC (' Three Part Advisors '), a leading full-service, strategic investor relations advisory firm headquartered near Dallas, Texas, for its ongoing investor relationship program, effective July 1, 2025. Three Part Advisors will work closely with management on the Company's strategic investor relations program, with a focus on enhancing Thunderbird's visibility within the investment community. This includes, but is not limited to, identifying and engaging with potential investors, organizing investor presentations and meetings with interested parties, responding to incoming calls from shareholders and potential investors, and providing general capital markets advisory services. Jennifer Twiner McCarron, CEO and Chair of Thunderbird, commented, 'We're pleased to welcome Three Part Advisors as our new strategic investor relations advisory firm. Given our significant growth plans and the health of our business, we believe this is an opportune time to share the Thunderbird story with a broader investor audience.' Steven Hooser, Partner of Three Part Advisors, said, 'We are thrilled to welcome Thunderbird Entertainment to our growing base of diverse clients. We know that introducing the Company to the right investors looking for growth and a strong management team is vital, and Thunderbird has built a global content creation studio of premium, award-winning content and distribution that will generate excitement from fundamental investors across our network.' Three Part Advisors has been retained for an initial period of one year, commencing July 1, 2025, at a rate of $12,500 USD per month. Three Part Advisors has no interest, directly or indirectly, in the Company or its securities, or any right or intent to acquire such an interest, other than as described herein. Market Making Services Correction Thunderbird is correcting language from an announcement made on October 23, 2024. The agreement with the Independent Trading Group to provide market making services in accordance with TSX Venture Exchange policies was for an initial term of one month and renewable thereafter. About Three Part Advisors, LLC Three Part Advisors, LLC is a leading full-service, strategic investor relations advisory firm. Through measurable and proactive investor relations programs, the firm helps clients develop their investment thesis, effectively communicate the strategy to Wall Street, meet new investors and ultimately, lower the cost of capital. Three Part Advisors also provides corporate design services and annually holds three independent IDEAS investor conferences ( Unbiased by investment banking fees and trading commissions, Three Part Advisors has a proven reputation for engaging with companies that are supported by strong investment merits and proven fundamentals, and proactively communicating their stories to Wall Street in the most effective manner. More information is available at About Thunderbird Entertainment Thunderbird Entertainment (TSXV: TBRD, OTCQX: THBRF) is a global award-winning, full-service multiplatform production, distribution and rights management company, headquartered in Vancouver, with teams in Los Angeles and Ottawa. Thunderbird creates award-winning scripted, unscripted, and animated programming for the world's leading digital platforms, as well as Canadian and international broadcasters. The Company develops, produces, and distributes animated, factual, and scripted content through its various content arms, including Thunderbird Kids and Family (Atomic Cartoons), Thunderbird Unscripted (Great Pacific Media) and Thunderbird Scripted. Productions under the Thunderbird umbrella include Mermicorno: Starfall, Super Team Canada, Molly of Denali, Highway Thru Hell, Kim's Convenience, Boot Camp and Sidelined: The QB and Me. Thunderbird Distribution and Thunderbird Brands manage global media and consumer products rights, respectively, for the Company and select third parties. Thunderbird is on Facebook, X, and Instagram at @tbirdent. For more information, visit: Neither the TSXV nor its Regulation Services Provider (as that term is defined in the policies of the TSXV) accepts responsibility for the adequacy or accuracy of this release, which has been prepared by management. Cautionary Statement Regarding Forward-Looking Information Certain statements contained in this news release may contain forward-looking information or may be forward-looking statements (collectively, 'forward-looking statements') within the meaning of applicable securities laws. Forward-looking statements may be identified by words such as 'anticipate', 'continue', 'estimate', 'expect', 'forecast', 'may', 'will', 'plan', 'project', 'should', 'believe', 'intend', or similar expressions concerning matters that are not historical facts. Forward-looking statements in this press release include, but are not limited to, statements regarding Thunderbird's retention of Three Part Advisors, LLC as its new investor relations advisory firm, the anticipated benefits of this engagement, including enhancing Thunderbird's visibility within the investment community, increasing investor awareness and engagement, supporting the Company's growth and shareholder value, and the implementation of a proactive investor awareness program aimed at increasing shareholder engagement, trading volume, and attracting long-term investors. Forward-looking statements are necessarily based on a number of estimates and assumptions that, while considered reasonable, are subject to known and unknown risks, uncertainties and other factors which may cause actual results and future events to differ materially from those expressed or implied by such forward-looking statements. Such factors include, but are not limited to: general business, economic and social uncertainties; litigation, legislative, environmental and other judicial, regulatory, political and competitive developments; product capability and acceptance; international risk and currency exchange rates; and technology changes. The forward-looking statements or information contained in this document represent our views as of the date hereof and as such information should not be relied upon as representing our views as of any date subsequent to the date of this document. The Company undertakes no obligation to update publicly or revise any forward-looking statements or information, whether as a result of new information, future events or otherwise, unless so required by applicable securities laws. Accordingly, readers are cautioned not to place undue reliance on forward-looking statements or information.
Business Wire
2 hours ago
- Business Wire
AM Best Affirms Credit Ratings of Helvetica Re Rückversicherung AG Corporation
BUSINESS WIRE)-- AM Best has affirmed the Financial Strength Rating of A- (Excellent) and the Long-Term Issuer Credit Rating of 'a-' (Excellent) of Helvetica Re Rückversicherung AG Corporation (Helvetica) (Barbados). The outlook of these Credit Ratings (ratings) is stable. The ratings reflect Helvetica's balance sheet strength, which AM Best assesses as strongest, as well as its adequate operating performance, limited business profile and appropriate enterprise risk management. The company is Barbados-domiciled and began commercial operations in 2022, underwriting surety for renewable energy and infrastructure developments in Spain seeking further geographic diversification in Latin American markets. Until 2025, the company was originally named Berliner Re Reinsurance Company Inc. The ratings of Helvetica also reflect its strongest level of risk-adjusted capitalization, as measured by Best's Capital Adequacy Ratio (BCAR), adequate reinsurance program and conservative investment strategy aimed at providing liquidity and maintaining appropriate asset-liability management. Partially offsetting these positive rating factors are Helvetica's business profile, which is bounded by its current concentration in a single business line and distribution channel, as well as the highly competitive landscape in its target geographic markets' surety bond segment amid a challenging economic environment. Helvetica's risk-adjusted capitalization stands at the strongest level underpinned by a robust capital base and low underwriting leverage in conjunction with its conservative investment allocation. In AM Best's view, the company's operating performance is pressured by its high administrative expense structure, due to its startup nature; nevertheless, a continuously expanding top line in conjunction with well-contained claims and consistent inflow of investment income is expected to enhance bottom line results within the short term. Helvetica constantly reviews its underwriting guidelines to improve the performance of its businesses. Additionally, reinsurance commissions stemming from its quota share agreement with counterparties with a good level of security, will contribute gradually to offset its high operating expense structure. Helvetica posted a net income of USD 2.3 million within its first year of operation in 2022, followed by USD 8.7 million in 2024, according to preliminary financials. Negative rating actions could occur if Helvetica's high growth levels in conjunction with higher country risk tiers deteriorate balance sheet strength to levels no longer supportive of the strongest level. Additionally, negative rating actions could occur if underwriting results fall short of AM Best's expectations and deteriorate to levels no longer supportive of an adequate operating performance assessment. Positive rating actions, while unlikely within the mid term, could occur if the company is able to achieve geographic expansion successfully, while maintaining premiums sufficiency. This press release relates to Credit Ratings that have been published on AM Best's website. For all rating information relating to the release and pertinent disclosures, including details of the office responsible for issuing each of the individual ratings referenced in this release, please see AM Best's Recent Rating Activity web page. For additional information regarding the use and limitations of Credit Rating opinions, please view Guide to Best's Credit Ratings. For information on the proper use of Best's Credit Ratings, Best's Performance Assessments, Best's Preliminary Credit Assessments and AM Best press releases, please view Guide to Proper Use of Best's Ratings & Assessments.
